Literature DB >> 1335554

A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta.

S G Matta1, J Weatherbee, B M Sharp.   

Abstract

The cytokines interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha are known to be potent effectors of ACTH secretion. Some of the peripheral effects of IL-1 beta appear to be related to the secretion of IL-6 induced by IL-1 beta. Thus, we evaluated the effect of IL-6 on ACTH secretion and its interaction with IL-1 beta. Rats received recombinant human (rhIL-6) or murine (rmIL-6) IL-6 through indwelling jugular cannulae. rhIL-6 (200 ng or 2 micrograms/rat) produced peak plasma ACTH levels which were 3- to 4-fold greater than basal levels. rmIL-6 produced similar responses. Neither species of IL-6 affected plasma prolactin levels. Comparison of rhIL-1 beta (200 ng) to rhIL-6 (200, 100 or 50 ng) showed that IL-6 elevated ACTH in a dose-dependent manner and that IL-1 beta was significantly more effective. IL-1 beta was also administered concomitantly with or 10 min after IL-6. Delivered together, IL-1 beta (100, 30 or 10 ng) and IL-6 (100 ng) produced significantly higher ACTH levels than when given alone. This additivity was also evident when IL-6 was given 10 min prior to IL-1 beta. The coadministration of IL-6 (2 micrograms) with corticotropin-releasing factor (CRF, 1 micrograms/kg, b.w.) also had an additive effect on ACTH secretion (at 20 min: 300 +/- 40 pg/ml for CRF; 320 +/- 83 pg/ml for IL-6; and 540 +/- 44 pg/ml for CRF + IL-6), whereas a higher dose of CRF (10 micrograms/kg b.w.) yielded ACTH levels of 1,000 +/- 107 pg/ml at 20 min, with no further enhancement by IL-6. Incubation of pituitary cells with IL-6 alone (0.1, 1.0 or 3.0 nM) produced a slight but significant stimulation of ACTH secretion within 2 h in response to the higher doses of IL-6 only (p < 0.05), but did not modify the effect of CRF in vitro. To determine if the action of IL-6 was at a site(s) within the brain, IL-6 (30 or 100 ng/0.5 microliters) was injected into the third cerebroventricle of alert rats. 100 ng IL-6 elicited peak plasma ACTH levels (300 +/- 65 pg/ml) within 30 min; these were significantly higher than the buffer responses (90 +/- 25 pg/ml, p < 0.01), and lower than the responses to 30 ng IL-1 beta (530 +/- 50 pg/ml, p < 0.001). 30 ng IL-6 was ineffective.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335554     DOI: 10.1159/000126269

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  9 in total

1.  Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.

Authors:  S K Lutgendorf; L Garand; K C Buckwalter; T T Reimer; S Y Hong; D M Lubaroff
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-09       Impact factor: 6.053

2.  Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.

Authors:  I Shimon; X Yan; D W Ray; S Melmed
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

3.  Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1 beta, TNF alpha and IL-6: a dose response study.

Authors:  M J van der Meer; C G Sweep; C E Rijnkels; G J Pesman; F J Tilders; P W Kloppenborg; A R Hermus
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

Review 4.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 5.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

Review 6.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

Review 7.  Elucidating the unexplained underperformance syndrome in endurance athletes : the interleukin-6 hypothesis.

Authors:  Paula Robson
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

8.  The plasma interleukin-6 and stress hormone responses to acute pyelonephritis.

Authors:  R A Donald; R R Bailey; D Hart; J H Livesey; M J Evans; L Mattioli; J Macdonald; A H Smith
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

9.  Interleukin-2 drives cortisol secretion in an age-, dose-, and body composition-dependent way.

Authors:  Ferdinand Roelfsema; Peter Y Liu; Rebecca Yang; Paul Takahashi; Johannes D Veldhuis
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.